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South African reports to the World Health Organization (WHO) 
indicate that its tuberculosis (TB) notifications have increased 
fivefold over the last 20 years; in 2008, South Africa (SA) had the 
third-highest TB burden, after India and China.1 SA and Swaziland 
now have the highest TB notification rates in the world, with about 
1% of their populations developing TB annually.1,2 SA was responsible 
for approximately 25% of the global burden of HIV-associated TB 
cases in 2007.2
While a worsening epidemic is revealed, data give little insight into 
understanding why TB control is failing. To better understand the 
epidemiology of TB control, the national and available community 
and city level data must be integrated; understanding this provides 
insights into the weaknesses of existing strategies and permits 
the development of additional rational interventions to regain TB 
control.
TB notifications
In 2007, 315 000 cases of TB were notified in South Africa – a 
rate of new and recurrent disease of 649 per 100 000 population.2 
Approximately 40% of nationally notified cases were tested for HIV 
infection, of which 73% were estimated to be positive, but this high 
prevalence may be affected by selection bias. The 2009 Cape Town 
(population 3.4 million) notification of 31 095 TB cases3 represents 
double the number of TB cases reported in the USA (population >300 
million people).2
Provider-initiated HIV testing in Cape Town TB clinics has 
increased to over 85%, allowing analysis of data stratified by age and 
HIV status, and providing a better understanding of the epidemiology 
of TB in a large urban population. Using denominators from the Cape 
Town population structure (Calle Hedberg, City of Cape Town and 
Stats SA) and TB notification data, age-specific TB notification rates 
stratified by HIV status were derived (Fig. 1). HIV-associated TB 
accounted for 44% of the total case burden. The peak TB notification 
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South Africa’s rate of tuberculosis (TB) has increased over the last 
20 years, to now having the third-highest TB burden in the world. 
The TB control programme has primarily focused on effective case 
management of passively presenting TB cases, and progress has been 
recorded towards international treatment targets. While outcomes 
for notified TB cases have improved, this strategy failed to contain 
the TB epidemic. South Africa has the highest per capita annual 
risk of TB disease of comparably sized countries globally, and its 
communities have extremely high TB transmission rates. The rates 
of TB infection of children and adolescents are now similar to those 
reported 100 years ago in Europe long before chemotherapy became 
available. High rates of HIV testing of TB patients in Cape Town 
allows analysis of TB notification data stratified by age, type of TB 
and HIV status, and a better understanding of TB epidemiology. 
TB infection prevalence data from Cape Town communities allow 
estimation of the prevailing force of TB infection and, together 
with TB notification and prevalence data, the effective number 
of secondary infections and case finding proportions can be 
estimated. This better understanding of the major drivers of the TB 
epidemic allows reasons to be identified for failure of the present 
strategy. New control strategies can also be identified, that must be 
accompanied by novel TB control targets.
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Fig. 1. Tuberculosis notifications in 2009 for the City of Cape Town stratified by 5-year age 
groups and by provider-initiated HIV testing results. The demominators for age strata derived 
from National Department of Health/Health Information System Programme by disaggregating 
StatsSA district estimates (November 2009) using data from the `Small Area Layer` (StatsSA, 
2004). 
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tion System Programme by disaggregating StatsSA district estimates (No-
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rate was among young adults, exceeding 1 400 per 100 000 population 
(Fig. 1). Of those aged between 25 years and 45 years, 63% of TB 
cases were HIV-associated. Of particular concern is that about 1% 
of children <5 years old were notified as having TB. Since children 
rapidly progress from TB infection to TB disease, childhood TB 
disease indicates recent ongoing TB transmission.4,5 These data 
strongly indicate very high transmission rates in the community.
The cumulative lifetime risk of new and recurrent TB of HIV-
uninfected individuals living in Cape Town was calculated by 
cumulatively adding the annual incidence of each 5-year age grouping 
(Fig. 2). The denominators for these calculations are the total age 
strata populations. As the HIV-infected population is included in the 
denominator, the resultant rate estimations are conservative. With 
the status quo, 1 in 5 individuals resident in Cape Town who remain 
HIV-uninfected will be at risk for developing TB before reaching the 
age of 60 years. This modern lifetime risk is unprecedented and is 
approximately twice that for individuals acquiring TB infection in the 
UK in the 1950s.6 The cumulative risk of TB disease for those who 
become HIV-infected is considerably higher. Therefore our TB control 
strategies have failed, resulting in the highest reported global rates of 
TB disease in children and HIV-infected and uninfected adults.
TB infection
The epidemiological transitions relevant to the pathogenesis of TB 
from exposure to death or cure are outlined in Fig. 3. As with other 
infectious diseases, the key primary event is the initial acquisition 
of infection. While there have been no recent systematic attempts 
to measure TB infection rates in South Africa, data from Cape 
Town report extremely high prevalence rates of TB infection among 
children and adolescents.7-10
In 2005, the prevalence of a positive (>10 mm induration) 
tuberculin skin test (TST) among 7 457 primary school children 
(median age 8.6 years) was 37.4%.7 A TST survey in a Cape Town 
school in 2005 reported TB prevalence to be 26.2% in 5 - 8-year-
olds, increasing to 52.5% in 14 - 17-year-olds.8 The prevalence of TB 
infection increased from 20% at school entry to 52% at 15 years, and 
reached 75% at 25 years in another study including HIV-negative 
adolescents and adults.9 Note also that a further 8% of the population 
will have developed TB disease by the age of 25 years (Fig. 2) and they 
were excluded from the prevalence surveys. In 2 neighboring urban 
communities with low HIV prevalence, a high prevalence of TB 
infection in children (6 - 9 years) was reported.10 Transmission rates 
increased between 1998 and 2005 and remained among the highest 
(4.1 - 5.8% per annum) in the world.10
Collectively, these studies indicate an extremely high prevalence of 
TB infection in Cape Town acquired during childhood, and that high 
rates of acquisition of TB infection continue throughout adolescence 
and into young adulthood. These high rates of TB transmission 
predate the HIV epidemic and have not declined over the last decade. 
Together with increasing TB notification rates, these data clearly 
indicate a failure of TB control.
Force of TB infection
The force of infection is the proportion of TB-uninfected individuals 
newly infected per annum, and is principally determined by the 
prevalence of infectious TB cases and the effective number of 
secondary cases infected by each infectious case. A TB prevalence 
survey of a random sample of the general population was conducted 
in a Cape township in 2005. The prevalence of laboratory-proven 
TB among HIV-uninfected and infected adults was 0.47% and 5.2% 
respectively.11 After the community scale-up of antiretroviral therapy 
(ART), the prevalence of TB among the HIV-uninfected population 
did not change, but the prevalence among HIV-infected adults 
decreased from 5.2% to 1.3%.12
Cape Town studies estimated the force of TB infection to be 
between 4% and 8% per annum.7-10 In historical perspective, these 
values are similar to the force of infection estimated for the UK 
population in the early decades of the 20th century, which was long 
before TB chemotherapy was developed. In 1900 in the UK, the force 
of infection was 10% per annum, declining to 1% around 1950 and 
to <0.01% by 2000.13
Fig. 4 shows the relationship between increasing force of infection 
and the proportion of the population with primary TB infection 
and the proportion multiply exposed to TB infection. Effective TB 
control interventions that produced small reductions in the force of 
infection in Cape Town could produce large benefits in transmission 
reduction. Reduction of the force of infection to 1% would decrease 
the proportion of the population exposed to multiple TB exposures 
from over 50% to <0.5% (β1 in Fig. 3) and the proportion acquiring 
primary infection would decrease from 75% to <30% (α in Fig. 3).
Effective contact number
An effective TB contact is defined as a contact between an infectious 
pulmonary case and a susceptible individual, sufficient to result in 
TB infection.14 The number of individuals infected by each case (the 
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Fig. 2. The accumulated life-time risk of being notified with new or relapsed tuberculosis 
calculated for HIV-negative individuals. Values are based on cumulative 2009 age-specific 
tuberculosis notification rates for Cape Town. 
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Fig. 3. An outline of tuberculosis transition states for a susceptible population from initial 
infecti n to disease and treatment outcome or death. The force of infection is shown as a 
functi n of prevalent untreated TB disease and determines the rate of primary TB infection () 
and the rate of multiple i fection exposures (1) of l tently infect d individuals. 2 is the 
progression rate from l tent to active disease,  the case-finding proportion,  the cure rate, and 
1 & 2 the off- and on-chemotherapy mortality rates respectively. 
 
Fig. 3. An outline of TB transition states for a susceptible population from 
initial infection to disease and treatment outcome or death. The force of in-
fection is shown as a function of prevalent untreated TB disease and deter-
mines the rate of primary TB infection (α) and the rate of multiple infection 
exposures (β1) of latently infected individuals. β2 is the progression rate from 
latent to active disease, γ the case-finding proportion, Δ the cure rate, and μ1 
and μ2 the off- and on-chemotherapy mortality rates respectively.
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effective contact number) is determined by the ratio of the force of 
infection and the prevalence of infectious pulmonary TB cases. The 
ratio between a force of infection of 4 - 8% (4 000 - 8 000/100 000) 
TB infection rate and a prevalence of smear-positive pulmonary 
cases notified during 2009 in Cape Town of 370/100 000 indicates 
an effective contact number of between 11 and 22. Historically, the 
effective contact number in the UK declined from 22 in 1900, to 10 
in 1950 and to 1 in 1990.13
For long-term control of an epidemic, the effective contact 
number must be lower than the number of individuals who can be 
expected to produce a single new case of infectious pulmonary TB 
during a lifetime. As the lifetime risk in Cape Town of developing 
smear-positive pulmonary TB among HIV-negative residents is 
approximately 10%, the effective contact number must be reduced to 
<10 to achieve a reduction in the TB epidemic. Current interventions 
are not achieving this.
Impact of the HIV epidemic
The South African HIV epidemic has expanded markedly over 
20 years, and it was recognised early that TB was a major cause 
of morbidity and mortality.15,16 A pertinent question is the degree 
to which the HIV-associated TB epidemic has caused the failure 
to control TB or the manifestation of the failure to contain TB 
transmission. Although 44% of the total TB case load in Cape Town 
in 2009 was HIV-related, only 14.3% of smear-positive pulmonary 
disease was HIV-related. It therefore appears likely that the HIV 
epidemic disproportionately increases TB case load rather than TB 
transmission.
There is no strong evidence that HIV-associated immune 
suppression affects the acquisition of TB infection (α Fig. 3). Instead, 
HIV infection appears to be associated with a marked increase in 
risk of progression from latent infection to TB disease, following 
either a primary (β2 Fig. 3)17-19 or recurrent exposure (β1 Fig. 3).20,21 
Case-finding proportions (γ Fig. 3) were reduced in HIV-infected 
individuals (44%) compared with HIV-uninfected (57%) in a Cape 
Town township.7 However, the population case-finding proportion 
improved following introduction of an ART programme (64%).8 TB 
case fatality (μ1 and μ2 Fig. 3) is increased particularly in those with 
low CD4 cell counts.22 ART partially reverses immune suppression23 
and can reduce risk of TB progression after recent TB exposure (β1 
Fig. 3) and, together with isoniazid preventive therapy, can decrease 
the progression from latent to active disease (β2 Fig. 3).24 Active 
case-finding within ART programmes markedly improves TB case 
finding.12,25-28
Why is TB control failing?
Broad existing strategies for TB control are case-finding and 
treatment of active disease, treatment of latent TB infection, and 
vaccination with bacille Calmette-Guérin (BCG).25 Universal BCG 
vaccination of all infants protects against progression to miliary TB 
and TB meningitis but does not affect TB transmission.29 Treatment 
of latently infected individuals with isoniazid prophylaxis has not 
been widely implemented in either HIV-infected or uninfected 
populations in SA.2
The SA TB control strategy predominantly focuses on the 
quality of case management of patients passively presenting to TB 
clinics. Passive case-finding is detection of active TB disease among 
symptomatic patients presenting to medical services, and is promoted 
in developing countries as part of the WHO-recommended DOTS 
strategy.30,31 Consequently, the primary targets and reporting statistics 
of the SA TB control programme has been the proportion of 
TB cases which are effectively treated under DOTS with anti-TB 
chemotherapy.1,2 SA national DOTS coverage increased from 77% to 
100% and the treatment success rate from 61% to 74% between 2001 
and 2006.1,2 However, TB notifications doubled in the same period.1,2
The TB burden was decreasing in industrialised countries before 
effective chemotherapy was introduced, with reductions in the force 
of infection from approximately 10% to 1% in the early 20th century.13 
Introducing effective chemotherapy in the 1950s consolidated these 
trends in improved TB control. While effective TB case management 
is necessary in TB control, it was, however, predicted that it would 
be insufficient for TB control in scenarios such as South Africa 
with a high force of infection, high proportion of latently infected 
individuals and a generalised HIV epidemic.32 The DOTS strategy 
is insufficient in high HIV-burdened settings.33 In high transmission 
settings where effective contact numbers are high, lower case-finding 
rates and delays in diagnosis and initiation of chemotherapy result in 
ongoing transmission.
Development of a new TB control 
strategy
The benefits of improved case-finding depend on the prevailing 
epidemiology of TB transmission. In a setting with a force of 
infection <1.0, detecting a case of TB will mainly benefit that 
individual alone. In contrast, the benefit of early detection of a TB 
case where there is an effective contact number >10 will additionally 
prevent up to 10 secondary cases. The benefits of increased and 
earlier case-finding on TB transmission are therefore significantly 
amplified in high-transmission settings. Decreasing TB infection 
rates is fundamental to achieving the long-term aim of TB control 
of a steady decline of disease in successive generations. Reducing 
the high force of TB infection, especially in high-density townships, 
should therefore become a primary target for long-term TB control. 
Historical TB control measures using community-based interventions 
such as enhanced and intensified case-finding strategies must be 
re-explored in view of the additional benefits accruing for decreasing 
transmission.25,34,35
Reducing the time period of infectiousness also directly influences 
the prevalence of infectious TB. The period of infectiousness results 
from delays including health-seeking behaviour, diagnostic delays and 
health systems delays in initiating effective chemotherapy. Intensified 
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Fig. 4. The relationship between ‘force of tuberculosis infection’ and proportion of population 
acquiring primary TB infection and multiple infectious exposures. The prevalence of primary 
infection is defined as P1=[
60x=0(1-exp(-Fx)]/61 and the prevalence of mul iple infection 
exposures is defined as P2=[
60x=0(1-exp(-Fx)-(Fx)exp(-Fx)]/61 where F is force of  infection 
and x is age. 
 
Fig. 4. The relationship between ‘force of tuberculosis infection’ and proportion 
of population acquiring primary TB infection and multiple infectious exposures. 
The prevalence of primary infection is defined as P1=[60Σx=0(1-exp(-Fx)]/61 and 
the prevalence of multiple infection exposures is defined as P2=[60Σx=0(1-exp(-
Fx)-(Fx) xp(-Fx)]/61 where F is force of TB infection and x is age.
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case-finding can increase awareness of typical symptoms of TB disease, 
thereby improving health-seeking behaviour. Diagnostic delays can 
be reduced by using newer molecular diagnostic technologies, and 
improved health systems efficiencies can further decrease time to 
initiation of effective TB therapy.
High-risk communities should be specifically targeted, and age-
specific interventions are necessary to interrupt TB transmission 
to infants and young children, school-age children and adolescents, 
and both HIV-negative and positive adult populations. A change in 
priority focus from case management to TB transmission reduction 
should be accompanied by incorporating new outcome measures 
that reflect ongoing TB transmission at national and sentinel sites. 
A reduction in TB disease rates among young children, and a steady 
decrease in the number of latently infected children at school entry 
and subsequently, would reflect a decrease of TB transmission to 
children. TB control among adults would be reflected by a decrease in 
the proportion of recent infections, a decrease in the effective contact 
number, and eventually a decrease in lifetime risk of TB disease. In 
HIV-infected patients, full implementation of existing ART guidelines 
will reduce the pre-ART TB disease burden. The TB infection rates 
of patients on ART probably reflect the current force of TB infection. 
The effectiveness of 6-month isoniazid prophylaxis therapy (IPT) to 
reduce TB disease in already latently infected individuals is very likely 
undermined where the force of TB infection is high and consistent 
with southern African data indicating little or no lasting benefit after 
6 months IPT.36,37
Changing the emphasis from individual benefit to population 
benefit has parallels with the concept of using ART as prevention, 
which has been modelled as a potential strategy to control the HIV 
epidemic.38,39 This may have an additional effect on control of HIV-
associated TB.40 The HIV force of infection is the result of prevalent 
community levels of HIV load and sexual networking, which can be 
reduced by widespread HIV testing and initiation of ART. Similarly 
for the TB epidemic, the drivers of the high force of infection are 
population prevalence of infectious TB cases and the effective contact 
number. Reducing the high force of TB infection, especially in high-
density townships, should therefore become a primary target for 
long-term TB control.
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